The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.

MLA

Fickentscher, Christoph, et al. “The Pathogenicity of Anti-Β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.” Journal of Immunology Research, vol. 2015, 2015, p. 638129. EBSCOhost, https://doi.org/10.1155/2015/638129.

APA

Fickentscher, C., Magorivska, I., Janko, C., Biermann, M., Bilyy, R., Nalli, C., Tincani, A., Medeghini, V., Meini, A., Nimmerjahn, F., Schett, G., Muñoz, L. E., Andreoli, L., & Herrmann, M. (2015). The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation. Journal of Immunology Research, 2015, 638129. https://doi.org/10.1155/2015/638129

Chicago

Fickentscher, Christoph, Iryna Magorivska, Christina Janko, Mona Biermann, Rostyslav Bilyy, Cecilia Nalli, Angela Tincani, et al. 2015. “The Pathogenicity of Anti-Β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.” Journal of Immunology Research 2015: 638129. doi:10.1155/2015/638129.